(Q34433327)

English

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nogueira FS

1

1 reference

Europe PubMed Central

2 August 2017

Moreira MA

2

1 reference

Europe PubMed Central

2 August 2017

Borja-Cabrera GP

3

1 reference

Europe PubMed Central

2 August 2017

Santos FN

4

1 reference

Europe PubMed Central

2 August 2017

Menz I

5

1 reference

Europe PubMed Central

2 August 2017

Parra LE

6

1 reference

Europe PubMed Central

2 August 2017

Xu Z

7

1 reference

Europe PubMed Central

2 August 2017

Chu HJ

8

1 reference

Europe PubMed Central

2 August 2017

Palatnik-de-Sousa CB

9

1 reference

Europe PubMed Central

2 August 2017

Luvizotto MC

10

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

23

1 reference

Europe PubMed Central

2 August 2017

40

1 reference

Europe PubMed Central

2 August 2017

4805-4810

1 reference

Europe PubMed Central

2 August 2017

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the Fucose-Mannose Ligand (FML)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

A cross-sectional study of Leishmania spp. infection in clinically healthy dogs with polymerase chain reaction and serology in Greece

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

PCR-based detection of canine Leishmania infections in formalin-fixed and paraffin-embedded skin biopsies: elaboration of a protocol for quality assessment of the diagnostic amplification reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Histological and immunohistochemical study of clinically normal skin of Leishmania infantum-infected dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Leishmania donovani: Surface membrane carbohydrates of promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

The role of phosphoglycans in Leishmania-sand fly interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Cytology of cutaneous lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymerase Chain Reaction Using Noninvasively Obtained Samples, for the Detection ofLeishmania infantumDNA in Dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Canine visceral leishmaniasis: a histopathological study of lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.011

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.05.011

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34433327&oldid=1966759802"